Zhongnan Medical Journal Press

Home Results

A total of 310 result was found. Results that relate to Drug

Signal mining for cutaneous adverse events associated with antibody-drug conjugates based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1091-1098.
8536 times 1553 times

QIAN Mengying ZHANG Yongyi SHAN Qing CHEN Yan LI Bing GUO Jinmin

Antibody-drug conjugate Cutaneous adverse event FAERS database Data mining Pharmacovigilance
Details
A case of acute kidney injury caused by oral sodium phosphate

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1183-1188.
10285 times 1883 times

PENG Qin WU Wenfeng WU Huiyi

Sodium phosphate oral solution Acute kidney injury Hypertension Adverse drug reaction
Details
A case report of psoriasis-like rash caused by tislelizumab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1189-1195.
10091 times 1932 times

LI Jie WANG Ronghua XIE Xiaolei

Tislelizumab Psoriasis-like rash Adverse drug reaction
Details
One case of anaphylaxis caused by pembrolizumab injection

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1196-1200.
7881 times 1420 times

HUANG Shuzhen CHEN Xiongjian

Pembrolizumab Anaphylaxis Adverse drug reaction
Details
Implementation and interpretation for proficiency testing of microbiological examination

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):229-236.
8075 times 1133 times

LI Zhiyuan ZHANG Jingyi WANG Siqi LI Zheyuan LIU Yi ZOU Weibin

Proficiency testing Non-sterile drugs Microbiological examination Implementation and interpretation
Details
Research progress of novel anti-VEGF therapy in the treatment of neovascular age-related macular degeneration with novel drugs

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):268-277.
11114 times 1489 times

HOU Huimin CHANG Xueke ZHANG Leying SONG Zongming

Neovascular age-related macular degeneration Pathogenesis Novel drugs
Details
Clinical application and research progress on drugs for treating dry eyes

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):278-289.
10777 times 1848 times

SHANG Peizhao JIANG Siqi JIN Min CUI Yulong ZHOU Quanying LI Lingjun

Dry eye Medication Permeation pathways Artificial tears Secretagogue Inflammatory pathways Nonsteroidal antiinflammatory drugs Corticosteroids Clinical application Research progress
Details
Research progress on the mechanism of genistein in Alzheimer's disease

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):290-299.
7934 times 1159 times

ZHAO Mingyong LING Yingchun LI Lingling ZHONG Fangfang

Genistein Phytoactive drugs Alzheimer's disease Neuroprotective Estrogen Research progress
Details
Research progress on drug resistance mechanism and treatment of drug-resistant tuberculosis

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):341-349.
10809 times 1735 times

ZHONG Shanshan PENG Yu MAO Rongrong WANG Fang FAN Sitong CHEN Jiajia

Drug-resistant tuberculosis Mechanisms of drug resistance Treatment Research progress Mycobacterium tuberculosis
Details
Current status and quality evaluation of domestic and foreign ophthalmic drug and device combination products

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):350-356.
7509 times 1287 times

WEI Zhihan HUANG Yuanli ZHAO Danmei DU Xiaodan KE Linnan XU Yun

Ophthalmology Drug-device combination products Corneal contact lenses Punctual plugs Intraocular lens Quality evaluation
Details
A case of toxic epidermal necrolysis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1314-1319.
10022 times 1645 times

HUANG Lingling LI Xialin HUANG Guangyao LUO Peng WANG Weimin WANG Junping

Pembrolizumab Lung cancer Toxic epidermal necrolysis Adverse drug reaction
Details
Data mining of adverse event of novel tetracycline-class drugs based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1229-1238.
11457 times 1862 times

LI Boyang HU Jing

New tetracycline-class Omadacycline Eravacycline Adverse drug events Data mining FAERS database
Details
Research hotspots and future trends of drug resistance mechanism in treatment of renal cell carcinoma based on bibliometric analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1276-1295.
9597 times 1630 times

ZHENG Xinyi XU Jiajun QIU Xiaoyan

Renal cell carcinoma Drug resistance Targeted therapy Immunotherapy Bibliometric analysis Visualization
Details
Analysis of a case of rocuronium-induced perioperative silent lung

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1320-1324.
9354 times 1496 times

GAO Qianqian XU Na SHEN Jianghua ZENG Yan

Rocuronium bromide Airway spasm Silent lung Adverse drug reaction
Details
Methodological study and clinical application of HPLC-MS/MS for the determination of olverembatinib in the plasma of leukemia patients

Published on Frontiers in Pharmaceutical Sciences 2024,28(3):472-480.
6894 times 1165 times

GUO Jinyan SUN Wenli LIU Rui LU Guangze LIU Hongxing WANG Lei

Olverembatinib High-performance liquid chromatography tandem mass spectrometry Therapeutic drug monitoring Leukemia Methodological study Chinical application
Details